Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Medicine Maker
  • Explore

    Explore

    • Latest
    • Features
    • Interviews
    • Business & Trends
    • Technology & Manufacturing
    • Product Profiles
    • White Papers

    Featured Topics

    • Biopharma
    • Small Molecules
    • Cell & Gene
    • Future of Pharma

    Issues

    • Latest Issue
    • Archive
    • Cell and Gene Therapy Supplement
  • Topics

    Topics

    • Drug Discovery
    • Development & Clinical
    • Formulation
    • Drug Delivery
    • Bioprocessing
    • Small Molecules
    • Cell and Gene
    • Facilities & Equipment
    • Outsourcing
    • Packaging
    • Supply Chain
    • Regulation & Standards
  • News & Blogs

    News & Blogs

    • Industry News
    • Research News
    • Blogs
  • Events
    • Live Events
    • Webinars
  • Community & Awards

    Community & Awards

    • Power List
    • Sitting Down With
    • Innovation Awards
    • Company of the Year Awards
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
    • eBooks
Subscribe
Subscribe
The Medicine Maker / Power List / 2017 / Industry Influencers / Fiona Greer

Fiona Greer

Global Director, BioPharma Services Development, SGS

  • Profile

Meet Fiona Greer

Passion
“I was always attracted to the investigative nature of analytical science – hence I studied Forensic Science at University. I was lucky to become involved with mass spectrometry – the ‘big-hitter’ of analytical tools. Exploring methods of interrogating glycoprotein structure is a particular focus. I’m also passionate about passing on the knowledge I’ve gained over the past 30 years to the next generation of analytical scientists.”

Pivotal moment
“A pivotal moment came early in my career, when I joined a small start-up company exploiting the then novel technique of fast ion bombardment mass spectrometry to sequence proteins and carbohydrates. In addition to developing the methods on new types of instruments, I was working to apply them to structural problems with colleagues in the emerging biotech industry. It was an exciting time to be developing new analytical technologies.”

Predictions
“Two of the major modern-day health crises, antibiotic resistance and diabetes should be given more priority. These are global challenges and so the major pharma companies should be leading the way. In my field, the potential for miniaturization of mass specs could lead to their use in the surgery for rapid and accurate diagnosis.”

False

Advertisement

Recommended

False

The Medicine Maker
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.